Inventor
LONGSHAW ALISTAIR IAN
GB20 patents
⚠️ This page may combine multiple inventors who share the name “LONGSHAW ALISTAIR IAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RESPIVERT LTD
18 patentsUS9108950B2Aug 18, 2015
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors
RESPIVERT LTD38 citations96
US9624196B2Apr 18, 2017
Inhibitor of p38 MAP kinase
RESPIVERT LTD15 citations92
US9475796B2Oct 25, 2016
1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors
RESPIVERT LTD12 citations92
US9447076B2Sep 20, 2016
Inhibitor of p38 map kinase
RESPIVERT LTD16 citations92
US9249125B2Feb 2, 2016
Pyrazole derivatives as p38 MAP inhibitors
RESPIVERT LTD30 citations91
US9724347B2Aug 8, 2017
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors
RESPIVERT LTD5 citations84
US10266519B2Apr 23, 2019
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors
RESPIVERT LTD6 citations82
US9850231B2Dec 26, 2017
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors
RESPIVERT LTD5 citations82
US10238658B2Mar 26, 2019
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors
RESPIVERT LTD3 citations73
US9993478B2Jun 12, 2018
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
RESPIVERT LTD2 citations73
US10294216B2May 21, 2019
Pyrazolyl ureas as kinase inhibitors
RESPIVERT LTD1 citations72
US10738032B2Aug 11, 2020
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitors
RESPIVERT LTD3 citations71
US11634406B2Apr 25, 2023
Inhibitor of p38 MAP kinase
RESPIVERT LTD0 citations62
US11142515B2Oct 12, 2021
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD0 citations61
US9884845B2Feb 6, 2018
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD1 citations61
US10813932B2Oct 27, 2020
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
RESPIVERT LTD0 citations52
US10815217B2Oct 27, 2020
Inhibitor of p38 MAP kinase
RESPIVERT LTD0 citations51
US10045980B2Aug 14, 2018
Inhibitor of p38 map kinase
RESPIVERT LTD0 citations51